Evidence
Addict Health. 2024 Feb;16(1):1-5. doi: 10.34172/ahj.2024.1467. Epub 2024 Feb 29.
ABSTRACT
BACKGROUND: Hepatic encephalopathy (HE) is a complex neuropsychiatric disorder indicated by a deterioration in the functioning of hepatocytes. Impaired brain function is observed in advanced alcoholic liver disease particularly manifesting as HE. The pathophysiology of alcohol-related HE remains unclear. Accordingly, this study aimed to assess alcoholism and socioeconomic status of patients with liver disease compared with stages of HE.
METHODS: This cross-sectional study was conducted on 62 alcoholic patients who have been consuming alcohol for more than 14 years. Patients were recruited based on the assessment of clinical symptoms and diagnosed according to the MELD and Child-Pugh scoring systems.
FINDINGS: Descriptive statistics including demographic details and clinical features of patients were classified based on alcoholism and socioeconomic status. Patients belonging to the lower- and middle-income classes were more in number with a mean age of 46.66±10.21 and 47.14±6.36 years, respectively compared to upper-middle- and upper-income classes. The amount of alcohol intake was 116.59±45.60 in the middle class and 110.0±62.45 in the upper class.
CONCLUSION: Increased progression of HE leads to a rise in the mortality rate due to higher consumption of alcohol. HE is a severe complication in alcohol-related liver cirrhosis that contributes to impaired cognitive function in patients.
PMID:38651030 | PMC:PMC11032619 | DOI:10.34172/ahj.2024.1467
Estimated reading time: 4 minute(s)
Latest: Psychiatryai.com #RAISR4D Evidence
Cool Evidence: Engaging Young People and Students in Real-World Evidence
Real-Time Evidence Search [Psychiatry]
AI Research
Alcoholism and Socioeconomic Status among Patients with Hepatic Encephalopathy in Association with Increased Mortality
🌐 90 Days
AI Virtual Reality Related Evidence Matrix
- Antidepressants in People With Chronic Liver Disease and Depression: When Are They Warranted and How to Choose the Suitable One?
- Liver cirrhosis in a patient with alcohol dependence and autoimmune hepatitis
- Mimicking chronic alcohol effects through a controlled and sustained ethanol release device
- COVID-19 in Individuals with Chronic Liver Diseases
- A PROTEIN COMPLEX OF LIVER ORIGIN ACTIVATES A PRO-INFLAMMATORY PROGRAM THAT DRIVES HEPATIC AND INTESTINAL INJURY IN ALCOHOL-ASSOCIATED LIVER DISEASE
- A PROTEIN COMPLEX OF LIVER ORIGIN ACTIVATES A PRO-INFLAMMATORY PROGRAM THAT DRIVES HEPATIC AND INTESTINAL INJURY IN ALCOHOL-ASSOCIATED LIVER DISEASE
- Correlation between magnetic resonance imaging proton density fat fraction (MRI-PDFF) and liver biopsy to assess hepatic steatosis in obesity
- THE GLOBAL EPIDEMIOLOGY OF NON-ALCOHOLIC FATTY LIVER DISEASE AND NON-ALCOHOLIC STEATOHEPATITIS AMONG PATIENTS WITH TYPE 2 DIABETES
- Mast cells and the gut-liver Axis: Implications for liver disease progression and therapy
- Serum autotaxin is a prognostic indicator of liver-related events in patients with non-alcoholic fatty liver disease
- Clinical and patient-reported outcomes in patients with chronic hepatitis B and C and non-alcoholic fatty liver disease from real-world practices in Saudi Arabia, Turkey and Egypt
- Clinical and patient-reported outcomes in patients with chronic hepatitis B and C and non-alcoholic fatty liver disease from real-world practices in Saudi Arabia, Turkey and Egypt
- The Role of Cytokines in the Pathogenesis and Treatment of Alcoholic Liver Disease
- Family-Based Contributors in Relapse and Relapse Prevention Among Patients with Substance Use Disorder: An Exploration of Risk and Prognostic Factors
- Novel blood and tissue-based mitochondrial D-loop mutations detected in an Iranian NAFLD patient cohort
- Clinical features of individuals with laboratory values suggestive of advanced liver fibrosis when first treated for alcohol use disorder
- The Impact of Peer Groups and Media on Increasing Trends in Substance Use and Abuse Among the General Population During COVID-19
- MiR-18 regulates lipid metabolism of non-alcoholic fatty liver disease via IGF1
- Supplementation of Micro- and Macronutrients-A Role of Nutritional Status in Non-Alcoholic Fatty Liver Disease
- Chronic exposure to ambient air pollution and the risk of non-alcoholic fatty liver disease: A cross-sectional study in Taiwan and Hong Kong
- Time trends in liver-related mortality in people with and without diabetes: Results from a population based study
- The role of EEG and neuroimaging in the diagnosis of non-convulsive status epilepticus in Subacute Encephalopathy with Seizures in Alcoholics (SESA syndrome): a case report and overview of the literature
- The role of EEG and neuroimaging in the diagnosis of non-convulsive status epilepticus in Subacute Encephalopathy with Seizures in Alcoholics (SESA syndrome): a case report and overview of the literature
- Prognostic value of metabolic dysfunction-associated steatotic liver disease over coronary computed tomography angiography findings: comparison with no-alcoholic fatty liver disease
- Correlation of alanine aminotransferase levels and a histological diagnosis of steatohepatitis with ultrasound-diagnosed metabolic-associated fatty liver disease in patients from a centre in Nigeria
- Hepatic compartment syndrome, a rare complication after any liver insult or liver transplantation: Three case reports and literature review
- Predictors for liver fibrosis in non-alcoholic patients with psoriatic diseases: A multicenter cross sectional-study
- Predictors for liver fibrosis in non-alcoholic patients with psoriatic diseases: A multicenter cross sectional-study
- Nonalcoholic steatohepatitis: A comprehensive updated review of risk factors, symptoms, and treatment
- Coexistence of metabolic-associated fatty liver disease and autoimmune or toxic liver disease
- The association between non-alcoholic fatty liver disease and urinary incontinence among adult females in the United States
- Ablation of secreted phosphoprotein-1 in hepatocytes increases fatty acid oxidation and ameliorates alcohol-associated liver disease
- Designing clinical trials to address alcohol use and alcohol-associated liver disease: an expert panel Consensus Statement
- Relationship between changes in blood glucose, glycosylated hemoglobin [HbA1c], cholesterol, and triglyceride and changes in hepatic enzymes
- Outcomes and risk factors for mortality in clostridioides difficile infection in patients with NAFLD and NASH
- Association of socioeconomic deprivation with outcomes in critically ill adult patients: an observational prospective multicenter cohort study
- Clinical Overview of Sarcopenia, Frailty, and Malnutrition in Patients With Liver Cirrhosis
- The role and mechanism of SUMO modification in liver disease
- Sarcopenia in cirrhosis: Unraveling the prevalence and relationships with liver disease severity and complications
- Sarcopenia in cirrhosis: Unraveling the prevalence and relationships with liver disease severity and complications
- Assessment of Blood Lead Levels in Mothers Addicted to Opium and Their Neonates in Kerman: A Cross-sectional Study
- Role of FXR in the development of NAFLD and intervention strategies of small molecules
- The Diagnostic Value of Liver Biopsy for Unexplained Liver Dysfunction: A Retrospective Study
- The Diagnostic Value of Liver Biopsy for Unexplained Liver Dysfunction: A Retrospective Study
- Comparison of size of the liver between patients with non-alcoholic fatty liver disease and healthy controls
- Substance Abuse and Sleep Quality in University Students
- Brief intervention for chronic liver disease patients with alcohol use disorder in a hepatology outpatient unit: Effects and limitations
- Brief intervention for chronic liver disease patients with alcohol use disorder in a hepatology outpatient unit: Effects and limitations
- Safety and Effectiveness of Liv.52 DS in Patients With Varied Hepatic Disorders: An Open-Label, Multi-centre, Phase IV Study
- Hepatic extracellular ATP/adenosine dynamics in zebrafish models of alcoholic and metabolic steatotic liver disease
- Maternal Substance Use and Early-Life Adversity: Inducing Drug Dependence in Offspring, Interactions, Mechanisms, and Treatments
- Pulmonary Dysfunction in Patients with Cirrhosis of the Liver: A Study of Pulmonary Function Tests and Arterial Blood Gases
- Hepatic steatosis, metabolic dysfunction and risk of mortality: findings from a multinational prospective cohort study
- Hepatic steatosis, metabolic dysfunction and risk of mortality: findings from a multinational prospective cohort study
- Recruitment or activation of mast cells in the liver aggravates the accumulation of fibrosis in carbon tetrachloride-induced liver injury
- Prevalence of at-risk MASH, MetALD and alcohol-associated steatotic liver disease in the general population
- Regulatory pathways and therapeutic potential of PDE4 in liver pathophysiology
- Comorbidity and multimorbidity in patients with cirrhosis, hospitalised in an internal medicine ward: a monocentric, cross-sectional study
- Role of prostaglandin E2 and its receptors in chronic liver disease
- Burden of Wilson Disease among patients and care partners in the United States: results from a cross-sectional survey
- Parosmia Is Positively Associated With Problematic Drinking, as Is Phantosmia With Depressive Symptoms
- Angiocrine signaling in sinusoidal homeostasis and liver diseases
- Critical care management of acute liver failure
- Role of resmetirom, a liver-directed, thyroid hormone receptor beta-selective agonist, in managing non-alcoholic steatohepatitis: a systematic review and meta-analysis
Evidence Blueprint
Alcoholism and Socioeconomic Status among Patients with Hepatic Encephalopathy in Association with Increased Mortality
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Alcoholism and Socioeconomic Status among Patients with Hepatic Encephalopathy in Association with Increased Mortality
🌐 365 Days
AI Virtual Reality Related Evidence Matrix
- Antidepressants in People With Chronic Liver Disease and Depression: When Are They Warranted and How to Choose the Suitable One?
- ERRgamma-inducible FGF23 promotes alcoholic liver injury through enhancing CYP2E1 mediated hepatic oxidative stress
- Exclusive liquor and cocktail consumption is associated with at-risk fibrosis among nonheavy alcohol users with metabolic dysfunction-associated steatotic liver disease
- Liver cirrhosis in a patient with alcohol dependence and autoimmune hepatitis
- Diagnostic Accuracy of Vibration Controlled Transient Elastography as Non-invasive Assessment of Liver Fibrosis in Patients with Non-alcoholic Fatty Liver Disease
- Association between Thyroid Hormones and Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis in Obese Individuals Undergoing Bariatric Surgery
- Ultrasonographic findings of metabolic dysfunction-associated fatty liver disease: A comparative study with non-alcoholic fatty liver disease and clinical characteristics
- Management of alcoholic hepatitis: A clinical perspective
- Elucidating the role of intrinsic adenosine A1 receptors in acute alcoholism using human induced pluripotent stem cell-derived hepatocytes
- Non-alcoholic fatty liver disease and periodontal disease: A systematic review and meta-analysis of cross-sectional studies
- Cause-specific mortality in patients with alcohol-related liver disease in Denmark: a population-based study
- Socio-economic status, functioning and cognition in young versus adult patients newly diagnosed with bipolar disorder and their unaffected relatives; results from a cross-sectional study
- The relationship between alcohol consumption and chronic kidney disease in patients with nonalcoholic fatty liver disease
- Sex differences in clinical characteristics and outcomes associated with alcoholic hepatitis
- Mimicking chronic alcohol effects through a controlled and sustained ethanol release device
- Health status of patients with liver transplantation by alcohol-related disease vs another etiology: a cohort study
- COVID-19 in Individuals with Chronic Liver Diseases
- Prevalence and impact on the outcome of myosteatosis in patients with cirrhosis: a systematic review and meta-analysis
- A PROTEIN COMPLEX OF LIVER ORIGIN ACTIVATES A PRO-INFLAMMATORY PROGRAM THAT DRIVES HEPATIC AND INTESTINAL INJURY IN ALCOHOL-ASSOCIATED LIVER DISEASE
- A PROTEIN COMPLEX OF LIVER ORIGIN ACTIVATES A PRO-INFLAMMATORY PROGRAM THAT DRIVES HEPATIC AND INTESTINAL INJURY IN ALCOHOL-ASSOCIATED LIVER DISEASE
- Correlation between magnetic resonance imaging proton density fat fraction (MRI-PDFF) and liver biopsy to assess hepatic steatosis in obesity
- THE GLOBAL EPIDEMIOLOGY OF NON-ALCOHOLIC FATTY LIVER DISEASE AND NON-ALCOHOLIC STEATOHEPATITIS AMONG PATIENTS WITH TYPE 2 DIABETES
- Mast cells and the gut-liver Axis: Implications for liver disease progression and therapy
- Socioeconomic inequalities in deaths of despair: Age heterogeneity in Canada's working age population
- Serum autotaxin is a prognostic indicator of liver-related events in patients with non-alcoholic fatty liver disease
- Hepatitis B virus infection status and clinical characteristics in patients with rheumatoid arthritis
- Clinical and patient-reported outcomes in patients with chronic hepatitis B and C and non-alcoholic fatty liver disease from real-world practices in Saudi Arabia, Turkey and Egypt
- Clinical and patient-reported outcomes in patients with chronic hepatitis B and C and non-alcoholic fatty liver disease from real-world practices in Saudi Arabia, Turkey and Egypt
- Corrected and republished from: Metabolic associated liver disease
- The Role of Cytokines in the Pathogenesis and Treatment of Alcoholic Liver Disease
- Hepatocellular Carcinoma in Ceará: Epidemiology and Treatment in a Reference Liver Transplant Center in Northeast Brazil
- Family-Based Contributors in Relapse and Relapse Prevention Among Patients with Substance Use Disorder: An Exploration of Risk and Prognostic Factors
- Novel blood and tissue-based mitochondrial D-loop mutations detected in an Iranian NAFLD patient cohort
- P049 Investigation of Liver Diseases by Ultrasound in Patients With Inflammatory Bowel Disease
- Analysis of clinical features and identification of risk factors in patients with non-alcoholic fatty liver disease based on FibroTouch
- Hepatic Fibrosis and Cancer: The Silent Threats of Metabolic Syndrome
- Association of metabolic syndrome components and NAFLD with quality of life: Insights from a cross-sectional study
- Non-invasive tools for liver steatosis and steatohepatitis predict incidence of diabetes, cardiovascular disease and mortality 20 years later: The ATTICA cohort study (2002-2022)
- Clinical features of individuals with laboratory values suggestive of advanced liver fibrosis when first treated for alcohol use disorder
- The Impact of Peer Groups and Media on Increasing Trends in Substance Use and Abuse Among the General Population During COVID-19
- MiR-18 regulates lipid metabolism of non-alcoholic fatty liver disease via IGF1
- Molecular insights on intracellular Wnt/β-catenin signaling in alcoholic liver disease
- Molecular insights on intracellular Wnt/β-catenin signaling in alcoholic liver disease
- Wilson Disease: Uncommon but Not to Be Forgotten
- Sirt6 ablation in the liver causes fatty liver that increases cancer risky by upregulating Serpina12
- Sirt6 ablation in the liver causes fatty liver that increases cancer risky by upregulating Serpina12
- Incidence, prevalence and mortality of chronic liver diseases in Sweden between 2005 and 2019
- Impact of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) on the expression and function of hepatobiliary transporters: A comprehensive mechanistic review
- NAFLD Fibrosis Progression and Type 2 Diabetes: The Hepatic-Metabolic Interplay
- Non-alcoholic fatty liver disease: pathophysiological concepts and treatment options
- Supplementation of Micro- and Macronutrients-A Role of Nutritional Status in Non-Alcoholic Fatty Liver Disease
- Chronic exposure to ambient air pollution and the risk of non-alcoholic fatty liver disease: A cross-sectional study in Taiwan and Hong Kong
- Liver Transplantation in Chronic Liver Disease and Acute on Chronic Liver Failure- Indication, Timing and Practices
- Liver Transplantation in Chronic Liver Disease and Acute on Chronic Liver Failure- Indication, Timing and Practices
- Fibroblast Growth Factor 21 in Chronic Hepatitis C: A Potential Non-Invasive Biomarker of Liver Status upon Viral Eradication
- Quantitative assessment of hepatic steatosis using label-free multiphoton imaging and customized image processing program
- Fatty liver is associated with significant liver inflammation and increases the burden of advanced fibrosis in chronic HBV infection
- ZONAL EXPRESSION OF STARD1 AND OXIDATIVE STRESS IN ALCOHOLIC-RELATED LIVER DISEASE
- Time trends in liver-related mortality in people with and without diabetes: Results from a population based study
- Non-alcoholic fatty liver disease-related hepatocellular carcinoma
- Self-management behaviours in adults with non-alcoholic fatty liver disease: a cross-sectional survey from China
- The role of EEG and neuroimaging in the diagnosis of non-convulsive status epilepticus in Subacute Encephalopathy with Seizures in Alcoholics (SESA syndrome): a case report and overview of the literature
- The role of EEG and neuroimaging in the diagnosis of non-convulsive status epilepticus in Subacute Encephalopathy with Seizures in Alcoholics (SESA syndrome): a case report and overview of the literature
- Type 2 diabetes, hepatic decompensation, and hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: an individual participant-level data meta-analysis